Tenofovir disoproxil CAS 201341-05-1

Tenofovir disoproxil CAS 201341-05-1

Identification

CAS Number

201341-05-1

Name

Tenofovir disoproxil

Synonyms

({[(2R)-1-(6-Amino-9H-purin-9-yl)-2-propanyl]oxy}méthyl)phosphonate de bis{[(isopropoxycarbonyl)oxy]méthyle} [French] [ACD/IUPAC Name]
(R)-(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl bis(carbonate)
201341-05-1 [RN]
Bis(((isopropoxycarbonyl)oxy)methyl) (((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonate
bis({[(propan-2-yloxy)carbonyl]oxy}methyl) ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate
Bis{[(isopropoxycarbonyl)oxy]methyl} ({[(2R)-1-(6-amino-9H-purin-9-yl)-2-propanyl]oxy}methyl)phosphonate [ACD/IUPAC Name]
Bis{[(isopropoxycarbonyl)oxy]methyl} ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate
Bis{[(isopropoxycarbonyl)oxy]methyl} {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy}methylphosphonate
Bis{[(isopropoxycarbonyl)oxy]methyl}-({[(2R)-1-(6-amino-9H-purin-9-yl)-2-propanyl]oxy}methyl)phosphonat [German] [ACD/IUPAC Name]
Carbonic acid, [[[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl][[[(1-methylethoxy)carbonyl]oxy]methoxy]phosphinyl]oxy]methyl 1-methylethyl ester [ACD/Index Name]
MFCD00952920 [MDL number]
Tenofovir disoproxil
({[(1R)-2-(6-aminopurin-9-yl)-isopropoxy]methyl}{[(methylethyl)oxycarbonyloxy]methoxy}carbonyloxy)methyl (methylethoxy)formate
(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate
[(R)-2-(6-amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid diisopropoxycarbonyloxymethyl ester
[[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphoryl]oxymethyl isopropyl carbonate
[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
[201341-05-1]
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide
201341-05-1 (free)
202138-50-9 (1:1 FUMARATE SALT)
9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine
9-[(R)-2-[[Bis[[(isopropoxycarbonyl)oxy] methoxy]phosphinyl]methoxy]propyl]adenine
BIS({[(PROPAN-2-YLOXY)CARBONYL]OXY}METHYL) {[(2R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL]OXY}METHANEPHOSPHONATE
Bis(isopropyloxymethylcarbonyl)PMPA
Bis(POC)PMPA
carbonic acid [[(1R)-2-(6-amino-9-purinyl)-1-methylethoxy]methyl-[(isopropoxy-oxomethoxy)methoxy]phosphoryl]oxymethyl isopropyl ester
carbonic acid [[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphoryl]oxymethyl isopropyl ester
carbonic acid [1-(6-aminopurin-9-yl)propan-2-yloxymethyl-[[oxo(propan-2-yloxy)methoxy]methoxy]phosphoryl]oxymethyl propan-2-yl ester
GS 4331-05 (1:1 Fumarate salt)
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63717
PMPA prodrug
QA-8716
Tenofovir (Disoproxil)
tenofovir bis(isopropyloxycarbonyloxymethyl) ester
Tenofovir Disoproxil free base
TENOFOVIR DISOPROXIL[ADENINE-8-3H]

SMILES

C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C

StdInChI

InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1

StdInChIKey

JFVZFKDSXNQEJW-CQSZACIVSA-N

Molecular Formula

C19H30N5O10P

Molecular Weight

519.44

MDL Number

MFCD00952920

Properties

Appearance

White powder

Safety Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Tenofovir disoproxil CAS 201341-05-1

Identification Methods

HNMR, HPLC

Available document

GMP, DMF

Purity

98% min

Shelf Life

2 years

Storage

Under room temperature away from light

Known Application

Often used as nucleotide antiviral drugs.

Watson International Ltd

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details. http://www.watson-int.com/tenofovir-disoproxil-cas-201341-05-1/